Alvizia Healthcare Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 16-11-2024
- Paid Up Capital ₹ 0.10 M
as on 16-11-2024
- Company Age 9 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -91.42%
(FY 2023)
- Profit 87.39%
(FY 2023)
- Ebitda 89.40%
(FY 2023)
- Net Worth -11.89%
(FY 2023)
- Total Assets -25.26%
(FY 2023)
About Alvizia Healthcare
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sumit Kumar, Radhe Goyal, and Yogesh Goyal serve as directors at the Company.
- CIN/LLPIN
U24232CH2015PTC035565
- Company No.
035565
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Jun 2015
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Chandigarh, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Alvizia Healthcare Private Limited offer?
Alvizia Healthcare Private Limited offers a wide range of products and services, including Protein Supplements, Fat Burners, Hair Care, Hair Growth for Men, Health Conditions, Liver Care, Mental Wellness, Amino Acids, Bone, Joint & Muscle Care, Popular Category.
Who are the key members and board of directors at Alvizia Healthcare?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sumit Kumar  | Whole-Time Director | 15-Mar-2021 | Current |
| Radhe Goyal | Director | 04-Jun-2015 | Current |
| Yogesh Goyal | Director | 04-Jun-2015 | Current |
Financial Performance of Alvizia Healthcare.
Alvizia Healthcare Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 91.42% decrease. The company also saw a substantial improvement in profitability, with a 87.39% increase in profit. The company's net worth observed a substantial decline by a decrease of 11.89%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Alvizia Healthcare?
In 2023, Alvizia Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Alvizia Healthcare?
Unlock and access historical data on people associated with Alvizia Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Alvizia Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Alvizia Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
